Literature DB >> 32473102

Framework for the implementation of advanced HIV disease diagnostics in sub-Saharan Africa: programmatic perspectives.

Zibusiso Ndlovu1, Rosie Burton2, Rosanna Stewart3, Helen Bygrave4, Teri Roberts4, Emmanuel Fajardo5, Anafi Mataka6, Elisabeth Szumilin7, Bernhard Kerschberger8, Gilles Van Cutsem9, Tom Ellman2.   

Abstract

Patients with advanced HIV disease have a high risk of mortality, mainly from tuberculosis and cryptococcal meningitis. The advanced HIV disease management package recommended by WHO, which includes diagnostics, therapeutics, and patient psychosocial support, is barely implemented in many different countries. Here, we present a framework for the implementation of advanced HIV disease diagnostics. Laboratory and point-of-care-based reflex testing, coupled with provider-initiated requested testing, for cryptococcal antigen and urinary Mycobacterium tuberculosis lipoarabinomannan antigen, should be done for all patients with CD4+ cell counts of 200 cells per μL or less. Implementation of the advanced HIV disease package should be encouraged within primary health-care facilities and task shifting of testing to lay cadres could facilitate access to rapid results. Implementation of differentiated antiretroviral therapy delivery models can allow clinicians enough time to focus on the management of patients with advanced HIV disease. Efficient up-referral and post-discharge systems, including the development of patient-centric advanced HIV disease literacy, are also crucial. Implementation of the advanced HIV disease package is feasible at all health-care levels, and it should be part of the core of the global response towards ending AIDS as a public health threat.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 32473102     DOI: 10.1016/S2352-3018(20)30101-6

Source DB:  PubMed          Journal:  Lancet HIV        ISSN: 2352-3018            Impact factor:   12.767


  5 in total

1.  Implementation of WHO guidelines on management of advanced HIV disease and its impact among TB co-infected patients in Tanzania: a retrospective follow-up study.

Authors:  Frank E Hassan; Mbazi Senkoro; Nicholaus P Mnyambwa; Amani Wilfred; Síle F Molloy; Harrieth Manisha; Sokoine Kivuyo; Sayoki G Mfinanga
Journal:  BMC Public Health       Date:  2022-05-27       Impact factor: 4.135

2.  Revisiting Co-trimoxazole Prophylaxis for African Adults in the Era of Antiretroviral Therapy: A Randomized Controlled Clinical Trial.

Authors:  Matthew B Laurens; Randy G Mungwira; Nginache Nampota; Osward M Nyirenda; Titus H Divala; Maxwell Kanjala; Felix A Mkandawire; Lufina Tsirizani Galileya; Wongani Nyangulu; Edson Mwinjiwa; Matthew Downs; Amy Tillman; Terrie E Taylor; Jane Mallewa; Christopher V Plowe; Joep J van Oosterhout; Miriam K Laufer
Journal:  Clin Infect Dis       Date:  2021-09-15       Impact factor: 9.079

3.  Prevalence and Mortality due to COVID-19 in HIV Co-Infected Population: A Systematic Review and Meta-Analysis.

Authors:  Min Liang; Ning Luo; Mafeng Chen; Chunna Chen; Shivank Singh; Shantanu Singh; Shifan Tan
Journal:  Infect Dis Ther       Date:  2021-05-03

4.  Feasibility of implementing the advanced HIV disease care package as part of community-based HIV/TB activities: a mixed-methods study protocol.

Authors:  Tinne Gils; Lutgarde Lynen; Josephine Muhairwe; Kamele Mashaete; Thabo Ishmael Lejone; Philip Joseph; Thulani Ngubane; Alfred Kipyegon Keter; Klaus Reither; Alastair van Heerden
Journal:  BMJ Open       Date:  2022-02-07       Impact factor: 2.692

5.  Lay testing cadres and point-of-care diagnostic tests for HIV and other diseases: An essential combination in health service delivery.

Authors:  Zibusiso Ndlovu; Tom Ellman
Journal:  PLoS Med       Date:  2021-11-24       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.